Anakinra for use in the treatment of bronchiolitis obliterans syndrome

摘要

An effective amount of an agent consisting of an IL-1 inhibitor for use in the treatment of bronchiolitis obliterans syndrome, wherein the IL-1 inhibitor is anakinra.